Brief: Pharmasimple H1 Revenue Restated For Labo Contract EUR 7.6 Million
July 11 (Reuters) - Pharmasimple SA ALPHS.PA :
* H1 REVENUE RESTATED FOR LABO CONTRACT EUR 7.6 MILLION
VERSUS
EUR 7.3 MILLION YEAR AGO
* SEES REVENUE GROWTH IN H2 2018
Source text for Eikon: ID:nACT54200
Further company coverage: ALPHS.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pharmasimple SA
See all newsBrief: Pharmasimple Says It Received Order To Suspend Stock Consolidation
Brief: Pharmasimple Says Stock Consolidation Approved
Brief: Pharmasimple H1 EBITDA Loss Widens To 3.6 Million Euros
Brief: Pharmasimple Announces Reverse Stock Split
Brief: Pharmasimple: Suspension Of OCA Drawdowns From Oct For At Least 6 Months